Mineralys (MLYS) is transitioning to a pre-commercial stage, supported by robust Phase 3 data and a strengthened cash ...

Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive ...

Q. I would like to know more about the use of testosterone replacement in men. My understanding is that a recent large-scale study showed that men using testosterone replacement therapy did not have ...

While the expanded approval fulfills an unmet meet in postmenopausal women, its benefits are marginal in that population.

Health-related social needs in HF, removing age from frailty scores, CIED concerns about smartwatches, and more.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ('Tonix” or the 'Company”), a fully-integrated commercial stage biotechnology company, today announced it has entered into a securities purchase ...

Background Depression is a risk factor and complication of coronary artery disease (CAD) that is associated with poor ...

Treating blood pressure with antihypertensives like blood vessel relaxers (ARB drugs) can provide increased life expectancy ...

In 2025, cardiology delved deeper into sex-specific risk factors and how to leverage them in prevention, Stacey Rosen says.

Persistent recruitment delays, high dropout rates, and missed timelines continue to slow global clinical trials, while data show that sub-Saharan Africa offers a largely untapped opportunity with ...